D.J. St. Germain’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

D.J. St. Germain’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$196K	Buy	1,239 +39	+3%	+$5.27K	0.01%	302
2026 Q1	$153K	Hold	1,200	–	–	0.01%	322
2025 Q4	$146K	Hold	1,200	–	–	0.01%	357
2025 Q3	$120K	Hold	1,200	–	–	﹤0.01%	373
2025 Q2	$99.5K	Hold	1,200	–	–	﹤0.01%	384
2025 Q1	$97.3K	Hold	1,200	–	–	﹤0.01%	334
2024 Q4	$108K	Buy	+1,200	New	+$116K	﹤0.01%	333

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

D.J. St. Germain's XBI Position: Q2 2026 in Review

D.J. St. Germain increased its State Street SPDR S&P Biotech ETF (XBI) stake by 3.3% in Q2 2026, buying an estimated $5.27K and bringing the position to 1,239 shares worth $196K. The position accounts for 0.01% of the portfolio, ranked #302.

D.J. St. Germain first reported a position in XBI in Q4 2024 and has held it in 7 quarters since. 932 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

D.J. St. Germain held 1,239 shares of State Street SPDR S&P Biotech ETF worth $196K as of Q2 2026.
D.J. St. Germain bought 39 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $5.27K.
State Street SPDR S&P Biotech ETF made up 0.01% of D.J. St. Germain's portfolio in Q2 2026, its #302 holding.
D.J. St. Germain first reported a position in State Street SPDR S&P Biotech ETF in Q4 2024 and has held it in 7 quarters since.
932 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on D.J. St. Germain's 13F filing for Q2 2026, filed 21 Jul 2026.